Outcomes after early treatment with hydroxychloroquine and azithromycin: An analysis of a database of 30,423 COVID-19 patients

BACKGROUND: Many studies have evaluated the use of hydroxychloroquine in COVID-19. Most retrospective observational studies demonstrate a benefit of using HCQ on mortality, but not most randomized clinical trials. METHODS: We analyzed raw data collected from a cohort of 30,423 patients with COVID-19...

Descripción completa

Detalles Bibliográficos
Autores principales: Brouqui, Philippe, Million, Matthieu, Parola, Philippe, Mccullough, Peter A., Raoult, Didier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10651676/
https://www.ncbi.nlm.nih.gov/pubmed/38024333
http://dx.doi.org/10.1016/j.nmni.2023.101188

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10651676/
https://www.ncbi.nlm.nih.gov/pubmed/38024333
http://dx.doi.org/10.1016/j.nmni.2023.101188

Ejemplares similares